A detailed history of Formidable Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Formidable Asset Management, LLC holds 788 shares of REGN stock, worth $532,522. This represents 0.14% of its overall portfolio holdings.

Number of Shares
788
Previous 826 4.6%
Holding current value
$532,522
Previous $868,000 4.61%
% of portfolio
0.14%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $38,915 - $45,666
-38 Reduced 4.6%
788 $828,000
Q2 2024

Aug 08, 2024

SELL
$883.2 - $1071.19 $43,276 - $52,488
-49 Reduced 5.6%
826 $868,000
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $82,144 - $90,394
91 Added 11.61%
875 $842,000
Q4 2023

Feb 07, 2024

SELL
$775.18 - $881.7 $14,728 - $16,752
-19 Reduced 2.37%
784 $688,000
Q3 2023

Nov 09, 2023

SELL
$692.45 - $844.37 $207,735 - $253,311
-300 Reduced 27.2%
803 $660,000
Q2 2023

Aug 15, 2023

BUY
$700.03 - $830.35 $128,805 - $152,784
184 Added 20.02%
1,103 $793,000
Q1 2023

May 09, 2023

SELL
$680.49 - $826.97 $615,162 - $747,580
-904 Reduced 49.59%
919 $755,000
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $24,680 - $31,145
43 Added 2.42%
1,823 $1.26 Million
Q2 2022

Aug 16, 2022

BUY
$548.35 - $738.84 $116,250 - $156,634
212 Added 13.52%
1,780 $1.05 Million
Q1 2022

May 04, 2022

BUY
$595.12 - $698.43 $58,321 - $68,446
98 Added 6.67%
1,568 $1.1 Million
Q4 2021

Feb 07, 2022

BUY
$543.48 - $670.97 $79,891 - $98,632
147 Added 11.11%
1,470 $928,000
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $759,441 - $900,910
1,323 New
1,323 $801,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.